Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals

Modern Rheumatology

Volumn 18, Issue 5, 2008, Pages 472-479

  Suzuki, Takeshi ^a   Tsutsumi, Akito ^a   Suzuki, Hiroyuki ^a   Suzuki, Eiji ^a   Sugihara, Makoto ^a   Muraki, Yoshifumi ^a   Hayashi, Taichi ^a   Chino, Yusuke ^a   Goto, Daisuke ^a   Matsumoto, Isao ^a   Ito, Satoshi ^a   Miyazawa, Keiji ^b   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Rheumatoid arthritis; Single nucleotide polymorphism; TNF ; Tristetraprolin; ZFP36

Indexed keywords

ADENINE; GUANINE; INFLIXIMAB; LUCIFERASE; TRISTETRAPROLIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; JAPANESE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRISTETRAPROLIN; YOUNG ADULT;

EID: 53549119956     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-008-0085-5     Document Type: Article

References (22)

1. DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem. 1990;265:19185-91.
2. Worthington MT, Amann BT, Nathans D, Berg JM. Metal binding properties and secondary structure of the zinc-binding domain of Nup475. Proc Natl Acad Sci USA. 1996;93:13754-9.
3. Lai WS, Stumpo DJ, Blackshear PJ. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem. 1990;265:16556-63.
4. Ogawa K, Chen F, Kim YJ, Chen Y. Transcriptional regulation of tristetraprolin by transforming growth factor-b in human T cells. J Biol Chem. 2003;278:30373-81.
5. Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA: Binding of tristetraprolin-related zinc finger proteins to AU-rich elements and destabilized of mRNA. J Biol Chem. 2000;275:17827-37.
6. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood. 2000;95:1891-9.
7. Boutaud O, Dixon DA, Oates JA, Sawaoka H. Tristetraprolin binds to the COX-2 mRNA 3′ untranslated region in cancer cells. Adv Exp Med Biol. 2003;525:157-60.
8. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science. 1998;281:1001-5.
9. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, et al. A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996;4:445-54.
10. Tsutsumi A, Suzuki E, Adachi Y, Murata H, Goto D, Kojo S, et al. Expression of tristetraprolin (G0S24) mRNA, a regulator of TNF-α production, in synovial tissues of patients with rheumatoid arthritis. J Rheumatol. 2004;31:1044-9.
11. Taylor GA, Lai WS, Oakey RJ, Seldin MF, Shows TB, Eddy RL Jr, et al. The human TTP protein: Sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res 1991;19:3454.
12. Lai WS, Thompson MJ, Taylor GA, Liu Y, Blackshear PJ. Promoter Analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. J Biol Chem. 1995;270:25266-72.
13. Lai WS, Thompson MJ, Blackshear PJ. Characteristics of the intron involvement in the mitogen-induced expression of Zfp-36. J Biol Chem. 1998;273:506-17.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
15. Steinbrocker O, Traeger C, Batterman R. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659-62.
16. Weyrich P, Lammers R, Fritsche A, Machicao F, Häring HU, Stefan N. A novel functional polymorphism (-336A/G) in the promoter of the partitioning-defective protein-6alpha gene is associated with increased glucose tolerance and lower concentrations of serum non-esterified fatty acids. Diabetologia. 2005;48:669-74.
17. Blackshear PJ, Phillips RS, Vazquez-Matias J, Mohrenweiser H. Polymorphisms in the genes encoding members of the tristetraprolin family of human tandem CCCH zinc finger proteins. Prog Nucleic Acid Res Mol Biol. 2003;75:43-68.
18. Carrick DM, Chulada P, Donn R, Fabris M, McNicholl J, Whitworth W, et al. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J Autoimmun. 2006;26:182-96.
19. Jang J, Lim DS, Choi YE, Jeong Y, Yoo SA, Kim WU, et al. MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 2006;8:R170.
20. Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): Requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001;3:293-8.
21. Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL, et al. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol. 2007;179:918-27.
22. Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, et al. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56:2160-9.